Search

Your search keyword '"Espina V"' showing total 204 results

Search Constraints

Start Over You searched for: Author "Espina V" Remove constraint Author: "Espina V"
204 results on '"Espina V"'

Search Results

1. Tumor-Draining Lymph Secretome En Route to the Regional Lymph Node in Breast Cancer Metastasis

5. Clinical proteomics and molecular pathology

7. Guidelines for the use and interpretation of assays for monitoring autophagy

8. Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands?

11. Milk proteins fractionation by dynamic filtration

19. RELACIÓN ENTRE RENDIMIENTO LABORAL Y SÍNDROME PREMENSTRUAL

20. Guidelines for the use and interpretation of assays for monitoring autophagy.

21. The use of hydrogel microparticles to sequester and concentrate bacterial antigens in a urine test for Lyme disease

22. Nanoparticles technology : Amplifying the effective sensitivity of biomarker detection to create a urine test for hGH

23. P5-13-03: Correlation of Clinical and Molecular Findings with Pathologic Response to Preoperative Lapatinib and Trastuzumab, Separately or in Combination, Prior to Neoadjuvant Chemotherapy for HER2 Positive Breast Cancer.

24. Correlation of molecular effects and pathologic complete response to preoperative lapatinib and trastuzumab, separately and combined prior to neoadjuvant breast cancer chemotherapy.

41. Pegylated, Steptavidin-Conjugated Quantum Dots Are Effective Detection Elements for Reverse-Phase Protein Microarrays

42. Clinical Proteomics:  Revolutionizing Disease Detection and Patient Tailoring Therapy

44. RELACIÓN ENTRE RENDIMIENTO LABORAL Y SÍNDROME PREMENSTRUAL

45. Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands?

46. Stratification of clear cell renal cell carcinoma by signaling pathway analysis

47. Tumorigenic and metastatic activity of human thyroid cancer stem cells

48. Protein pathway activation mapping of I-SPY 1 biopsy specimens identifies new network focused drug targets for patients with HR+/HER2-- tumors.

49. Protein pathway activation mapping of the I-SPY 1 biopsy specimens identifies new network focused drug targets for patients with triple negative tumors.

50. Protein biomarkers for subtyping breast cancer and implications for future research: a 2024 update.

Catalog

Books, media, physical & digital resources